Cite
HARVARD Citation
Armağan, B. et al. (2022). Antibodies to Both Ro52 and Ro60 for Identifying Sjögren's Syndrome Patients Best Suited for Clinical Trials of Disease‐Modifying Therapies. Arthritis care & research. 74 (9), pp. 1559-1565. [Online].